Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 4Sanofi
02 12Dr. Reddy's Laboratories
03 4Breckenridge Pharmaceutical
04 4Olpha
05 4Ever Pharma
06 21Accord healthcare
07 4Anabiosis S.A.
08 8Apotex Inc
09 4Aurobindo Pharma Limited
10 4Avansor Pharma Oy
11 4BASI
12 3Bioglan
13 4Bristol Laboratories Ltd
14 31Bristol Myers Squibb
15 4Celgene Corporation
16 4Cipla Medpro South Africa
17 8Day Zero Ehf
18 4Deva Holding AS
19 2Eugia Pharma
20 2Eurolab
21 2Farmoz Sociedade Tecnico Medicinal Sa
22 4GSK
23 4Greendex AS
24 12Grindeks AS
25 4Hetero Drugs
26 4JAMP PHARMA
27 16Juno Pharmaceuticals Pty Ltd
28 4Key Oncologics
29 12Krka
30 4Laboratorio Eczane Pharma
31 4Natco Pharma (Canada) Inc
32 4Newbury Pharmaceuticals AB
33 4Newbury Pharmaceuticals Ab
34 4Pinnacle Life Science
35 2Reig Jofre
36 12STADA Arzneimittel
37 1Sakar Healthcare
38 36Sandoz B2B
39 4Spirig Healthcare
40 4Strange France
41 4Tecnimede
42 26Teva Pharmaceutical Industries
43 23Viatris
44 4XYZ Pharma
45 14Zentiva
01 10CAP
02 24CAPSULE
03 32CAPSULE;ORAL
04 149Capsule
05 5Capsules
06 64Hard Capsule
07 12Hard Capsules
08 4Oral Solid Dosage Form
09 1Pomalidomide 1Mg 21 Combined Oral Use
10 1Pomalidomide 2Mg 21 Combined Oral Use
11 1Pomalidomide 3Mg 21 Combined Oral Use
12 1Pomalidomide 4Mg 21 Combined Oral Use
13 12capsule
14 31Blank
01 32Allowed
02 67Approved
03 44Authorized
04 24DISCN
05 6Generic
06 4Lead Market Dossiers- Filed
07 4Lead Market Dossiers- Tentative\nApproved in US
08 28Marketed
09 4Not Marketed
10 4Originator
11 60Prescription
12 4RX
13 66Blank
01 4APO-POMALIDOMIDE
02 4Davunfite
03 23Imnovid
04 1Imnovid 1 mg
05 1Imnovid 2 mg
06 1Imnovid 3 mg
07 1Imnovid 4 mg
08 4JAMP POMALIDOMIDE
09 4NAT-POMALIDOMIDE
10 28POMALIDOMIDE
11 8POMALYST
12 4Pomalidomid Avansor
13 4Pomalidomid Devatis
14 4Pomalidomida Accord
15 4Pomalidomida Eczane
16 4Pomalidomida Erawya
17 4Pomalidomida Krka
18 2Pomalidomida Sala
19 4Pomalidomida Stada
20 2Pomalidomida Teva
21 4Pomalidomide
22 1Pomalidomide 1 mg Cipla
23 1Pomalidomide 2 mg Cipla
24 1Pomalidomide 3 mg Cipla
25 1Pomalidomide 4 mg Cipla
26 17Pomalidomide Accord
27 4Pomalidomide Anabiosis
28 3Pomalidomide Bioglan
29 2Pomalidomide Eugia
30 4Pomalidomide Ever Pharma
31 4Pomalidomide Glenmark
32 8Pomalidomide Grindeks
33 8Pomalidomide Krka
34 8Pomalidomide Newbury
35 4Pomalidomide Olpha
36 32Pomalidomide Sandoz
37 4Pomalidomide Spirig HC
38 8Pomalidomide Stada
39 4Pomalidomide Stragen
40 2Pomalidomide Tecnogen
41 12Pomalidomide Teva
42 19Pomalidomide Viatris
43 18Pomalidomide Zentiva
44 4Pomalidomide-Teva
45 4Pomalidomide-Teva Mepha
46 8Pomalyst
47 1Pomaxel 3 mg
48 1Pomaxel 4 mg
49 16Pomolide
50 4REDDY-POMALIDOMIDE
51 4SANDOZ POMALIDOMIDE
52 4Sulabcote
53 21Blank
01 4Argentina
02 36Australia
03 24Canada
04 36Estonia
05 13India
06 4Italy
07 8Latvia
08 1Moldova
09 32Norway
10 4Portugal
11 10South Africa
12 44Spain
13 67Sweden
14 32Switzerland
15 32USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Pomalidomide Zentiva
Dosage Form : Hard Capsule
Dosage Strength : 1mg
Packaging :
Approval Date : 03/06/2024
Application Number : 69057
Regulatory Info : Allowed
Registration Country : Switzerland
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 1MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Regulatory Info : DISCN
Registration Country : USA
Brand Name : POMALIDOMIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 1MG
Packaging :
Approval Date : 2020-10-30
Application Number : 210111
Regulatory Info : DISCN
Registration Country : USA
Olpha, a JSC AB City subsidiary, is a leading Baltic firm with 50 years of experience in medicines & chemical pharmaceuticals.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Pomalidomide Olpha
Dosage Form : Hard Capsules
Dosage Strength : 1MG
Packaging :
Approval Date : 06-08-2025
Application Number : 90487
Regulatory Info : Authorized
Registration Country : Spain
Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Pomalidomide Ever Pharma
Dosage Form : Capsule
Dosage Strength :
Packaging :
Approval Date : 18/12/2024
Application Number : 20230928000125
Regulatory Info : Approved
Registration Country : Sweden
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Pomalidomide Zentiva
Dosage Form : Hard Capsule
Dosage Strength : 2mg
Packaging :
Approval Date : 03/06/2024
Application Number : 69057
Regulatory Info : Allowed
Registration Country : Switzerland
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Pomalidomide Zentiva
Dosage Form : Hard Capsule
Dosage Strength : 3mg
Packaging :
Approval Date : 03/06/2024
Application Number : 69057
Regulatory Info : Allowed
Registration Country : Switzerland
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Pomalidomide Zentiva
Dosage Form : Hard Capsule
Dosage Strength : 4mg
Packaging :
Approval Date : 03/06/2024
Application Number : 69057
Regulatory Info : Allowed
Registration Country : Switzerland
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 2MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 3MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 4MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Tentative\\nApproved in US
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 1MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Tentative\\nApproved in US
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Tentative\\nApproved in US
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 2MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Tentative\\nApproved in US
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Tentative\\nApproved in US
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 3MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Tentative\\nApproved in US
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Tentative\\nApproved in US
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 4MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Tentative\\nApproved in US
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : REDDY-POMALIDOMIDE
Dosage Form : CAPSULE
Dosage Strength : 1MG
Packaging :
Approval Date :
Application Number : 2504073
Regulatory Info : Prescription
Registration Country : Canada
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : REDDY-POMALIDOMIDE
Dosage Form : CAPSULE
Dosage Strength : 2MG
Packaging :
Approval Date :
Application Number : 2504081
Regulatory Info : Prescription
Registration Country : Canada
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : REDDY-POMALIDOMIDE
Dosage Form : CAPSULE
Dosage Strength : 3MG
Packaging :
Approval Date :
Application Number : 2504103
Regulatory Info : Prescription
Registration Country : Canada
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : REDDY-POMALIDOMIDE
Dosage Form : CAPSULE
Dosage Strength : 4MG
Packaging :
Approval Date :
Application Number : 2504111
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : DISCN
Registration Country : USA
Brand Name : POMALIDOMIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 2MG
Packaging :
Approval Date : 2020-10-30
Application Number : 210111
Regulatory Info : DISCN
Registration Country : USA
